glp-1 colorectal cancer death risk study november 2025 Agents vs Aspirin: A New Era in Prevention Could GLP-1 medications help slow

They also show promise for the treatment of many inflammatory diseases including asthma and inflammatory bowel disorders like Crohns disease and ulcerative colitis Diagram showing food stimulating the release of GLP-1 into the intestine and its effects on the brain, stomach and pancreas Importance In 2023 GLP-1 based drugs was named breakthrough of the year by Science , a prestigious American journal

[DOI] [PMC free article] [PubMed] [Google Scholar] 120.Passilly-Degrace P, Chevrot M, Bernard A, Ancel D, Martin C, Besnard P

For more information on CVS Pharmacys GLP1 support offerings, visit www.CVS.com/GLP1

Among men whose low testosterone has an obesity-related cause the MOSH population many will have been offered or already be taking testosterone replacement therapy, often without a full discussion of its fertility consequences

Basic science and clinical research evidence indicates that GLP-1RAs produce direct immunomodulatory actions that function separately from weight loss

A similar beneficial association was seen in an observational study of semaglutide in 83,825 patients with obesity and 598,803 patients with T2DM over 12 months 112 , as well as in 87,676 new users of GLP-1RAs or DPP-4 inhibitors over 4 years 113